摘要
Clinical management of acute corneal alkali burns is limited by tear washout and the failure of monotherapies to break the inflammation-neovascularization cycle. To address this, we developed a thermosensitive hydrogel (PRP/QR@gel) co-loaded with platelet-rich plasma (PRP) and quercetin (QR). The low-viscosity precursor adaptively fills irregular defects and solidifies around ocular surface temperature, establishing a tear-resistant drug depot. Mechanistically, the rapid release of hydrophilic PRP drives ordered corneal remodeling via the PI3K/Akt/mTOR pathway. Concurrently, the sustained release of hydrophobic QR scavenges ROS, suppresses NF-κB-mediated inflammation, and blocks HIF-1α/VEGF-driven pathological neovascularization. In a rabbit alkali burn model, PRP/QR@gel accelerated complete epithelialization within 7 days and reduced clinical opacity scores by 50%. This in situ-forming hydrogel offers a translatable solution for severe ocular chemical injuries.
危险品化学品经营许可证(带存储)